Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

GSTC

Globestar Therapeutics (PK) (GSTC)

Globestar Therapeutics Corporation (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:GSTC
DateTimeSourceHeadlineSymbolCompany
02/15/202410:33AMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:GSTCGlobestar Therapeutics Corporation (PK)
01/19/20244:13PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:GSTCGlobestar Therapeutics Corporation (PK)
01/02/20243:21PMEdgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405USOTC:GSTCGlobestar Therapeutics Corporation (PK)
11/13/202311:32AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:GSTCGlobestar Therapeutics Corporation (PK)
08/17/20233:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:GSTCGlobestar Therapeutics Corporation (PK)
08/14/20233:31PMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:GSTCGlobestar Therapeutics Corporation (PK)
06/27/20234:12PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
05/31/20235:03AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
05/15/20233:16PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
05/03/202312:35PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
05/03/202312:30PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
04/06/20233:02PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
02/13/20234:17PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
01/09/202312:48PMEdgar (US Regulatory)Annual Report (10-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
12/29/20223:37PMEdgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
08/22/20224:31PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
08/15/20223:29PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
05/16/20223:55PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
10/12/20217:28AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
10/04/20217:49AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
09/20/20217:17AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
11/16/20184:30PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
11/16/20184:25PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
11/16/20184:04PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
11/14/20189:50AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
11/14/20189:40AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
11/14/20189:38AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
11/14/20188:44AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
11/08/20183:37PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
11/07/20183:28PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:GSTCGlobestar Therapeutics Corporation (PK)
 Showing the most relevant articles for your search:USOTC:GSTC